Inactive Instrument
NovImmune SA Stock
Stocks
IPO-NOVI
CH0010924170
Biotechnology & Medical Research
|
End-of-day quote
Swiss Exchange
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Nicolas Fischer
CEO | Chief Executive Officer | - | 2019-06-30 |
Nathalie Muller
ADM | Chief Administrative Officer | - | 1999-12-31 |
Hartmut Wekerle
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 81 | 2008-01-31 | |
| Director/Board Member | - | - | |
Tuygan Göker
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.80% | +8.47% | +64.65% | +77.70% | 66.87B | |
| +1.63% | +4.93% | +24.89% | +102.90% | 56.55B | |
| +0.07% | +1.39% | +12.75% | +76.61% | 57.2B | |
| +0.48% | -3.85% | +25.87% | +33.30% | 43.47B | |
| -6.51% | -0.78% | +218.15% | +776.46% | 42.8B | |
| +4.20% | +5.93% | +22.46% | +100.66% | 42.95B | |
| +1.59% | -4.04% | +97.66% | +81.57% | 32.11B | |
| +7.50% | +13.28% | +28.05% | +64.46% | 34.01B | |
| -2.34% | -3.34% | -42.28% | +352.43% | 24.13B | |
| Average | +1.17% | +3.98% | +50.24% | +185.12% | 44.45B | |
| Weighted average by Cap. | +1.32% | +3.91% | +52.38% | +169.26% |
Employees
-
- Stock Market
- Stocks
- IPO-NOVI Stock
Select your edition
All financial news and data tailored to specific country editions
